Skip to main content

Table 2 Inhaled Corticosteroid (ICS) use and risk of Herpes Zoster in 8900 cases and 88032 controls

From: Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study

  Cases Controls Crude odds ratio Adjusted odds ratio* (95% CI†)
ICS     
no use% 45.4 46.9 1.00 Reference
high dose% 13.1 11.6 1.19 1.05 (0.96-1.14)
medium dose% 14.3 14.7 1.01 0.97 (0.90-1.05)
low dose% 2.9 2.9 1.05 1.02 (0.89-1.17)
  1. *Adjusted for gender, smoking status, all the variables in Table 1, as well as past use of ICS.
  2. †CI: confidence interval